• Laminin (925-933): Precision Control in Cell Adhesion Assays

  2026-06-21

  Laminin (925-933) streamlines cell adhesion and chemotaxis workflows with unmatched specificity and solubility, enabling highly reproducible studies in cell migration and metastasis. Discover protocol enhancements, troubleshooting strategies, and cross-comparisons that unlock new assay reliability for extracellular matrix research.

• Efficient GRO-seq Protocol Enhances Nascent RNA Profiling in

  2026-06-20

  Chen et al. present a cost-effective and streamlined GRO-seq protocol featuring rRNA depletion for enhanced detection of nascent RNAs in bread wheat. This methodological advance dramatically increases valid sequencing data yield and is adaptable to other complex plant and animal genomes.

• Fluconazole as a Fungal Cytochrome P450 Enzyme Inhibitor in

  2026-06-19

  Fluconazole enables precise modeling of fungal pathogenesis, drug resistance, and antifungal susceptibility in both in vitro and in vivo systems. This guide details robust workflows, troubleshooting strategies, and data-driven insights that help researchers maximize reproducibility and depth in their antifungal studies.

• Mitofusin 2 Modulates Endothelial Senescence in Vascular Agi

  2026-06-19

  This study uncovers how Angiotensin II accelerates vascular endothelial cell senescence by downregulating mitofusin 2 (MFN2) and activating BCL6, providing mechanistic insight into vascular aging. The findings suggest that maintaining MFN2 levels may counteract age-related endothelial dysfunction, with practical implications for hypertension and vascular disease research.

• Ultra Fast LC–MS/MS for Cefazedone and Etimicin Pharmacokine

  2026-06-18

  This reference study established a rapid and validated UFLC–MS/MS method for the simultaneous quantification of cefazedone and etimicin in beagle dog plasma, enabling detailed pharmacokinetic analysis of their co-administration. The approach enhances precision in monitoring combination antibiotic therapy, supporting safer and more effective dosing strategies in translational and preclinical research.

• Radicicol: Hsp90 Inhibitor for Advanced Cell Fate Research

  2026-06-18

  Radicicol excels as a potent Hsp90 inhibitor and apoptosis enhancer, uniquely enabling mechanistic research in adipogenesis, oncology, and sepsis inflammation modeling. This guide details optimized experimental workflows, troubleshooting strategies, and actionable insights rooted in recent cross-presentation innovations.

• IBDV VP3 Protein Promotes IRF7 Degradation via Proteasome Pa

  2026-06-17

  This study uncovers how infectious bursal disease virus (IBDV) uses its VP3 protein to suppress interferon regulatory factor 7 (IRF7) through proteasome-mediated degradation, promoting viral replication in chicken cells. These findings clarify a specific immune evasion strategy of IBDV and suggest new avenues for dissecting host–virus interactions within the ubiquitin-proteasome system.

• Lisinopril dihydrate: A Benchmark Long-Acting ACE Inhibitor

  2026-06-17

  Lisinopril dihydrate is a highly selective, long-acting ACE inhibitor with an IC50 of 4.7 nM, validated for hypertension and cardiovascular research. Its purity, solubility, and specificity make it a gold-standard tool in translational studies targeting the renin-angiotensin system.

• Firefly Luciferase mRNA (ARCA, 5-moUTP): Mechanism & Evidenc

  2026-06-16

  Firefly Luciferase mRNA (ARCA, 5-moUTP) is an engineered bioluminescent reporter mRNA that enables robust, low-immunogenicity gene expression assays. Its ARCA capping and 5-methoxyuridine modification provide enhanced translational efficiency and stability, with proven utility in both in vitro and in vivo imaging workflows.

• Cyclic Pifithrin-α Hydrobromide: p53 Inhibitor for Apoptosis

  2026-06-16

  Cyclic Pifithrin-α hydrobromide is a potent and selective p53 inhibitor used to block p53-mediated pathways such as apoptosis and growth arrest. It enables researchers to dissect DNA damage responses in cancer and neuroinflammation models. APExBIO supplies this compound under SKU A4477 for research applications.

• Maximizing Protein Stability: Advanced Uses of EDTA-Free Pro

  2026-06-15

  Discover how the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) elevates protein stability in complex workflows. This article offers a deep dive into its unique mechanisms, best practices for assay optimization, and actionable insights from recent cancer metabolism research.

• Dasatinib (BMS-354825): Unraveling Kinase Networks in Cancer

  2026-06-15

  Explore how Dasatinib (BMS-354825) enables advanced dissection of Src and Bcr-Abl kinase signaling in cancer research. This article uniquely details its mechanistic insights, practical assay considerations, and the translational relevance of recent multi-omics findings.

• Redefining Mubritinib: A Toxicophore for Mitochondrial Compl

  2026-06-14

  Stephenson et al. uncover that Mubritinib’s anti-cancer effects stem from direct inhibition of mitochondrial complex I, not HER2 targeting. Their findings identify a unique toxicophore motif responsible for both efficacy and cardiotoxicity, reshaping the interpretation of Mubritinib and related compounds in cancer biology.

• Temporal COX-2 Inhibition Modulates Muscle Revascularization

  2026-06-13

  This study illuminates the dual, time-dependent effects of the cyclooxygenase-2 (COX-2) pathway in skeletal muscle ischemia and revascularization following Bothrops asper venom injury. By leveraging selective COX-2 inhibition with lumiracoxib, the research uncovers how early versus late intervention differentially impacts acute ischemia and subsequent angiogenic remodeling, informing the design of temporally precise muscle regeneration models.

• Puerarin Drives Osteogenic Differentiation via Nitric Oxide

  2026-06-12

  This study demonstrates that puerarin enhances the osteogenic differentiation of rat dental follicle cells by activating the nitric oxide (NO) pathway. Importantly, the promotive effects of puerarin are reversed by L-NMMA, confirming the centrality of NO signaling in this process and underscoring new avenues for periodontal regeneration research.

649 records 6/44 page Previous Next First page 上5页 678910 下5页 Last page